Genomma Opts for FRN

Jul 2, 2013

Given strong demand for floating-rate bonds as yields rise, Genomma Lab has opted for a floating-rate tranche over a 10-year fixed portion in its MXP2bn ($154m) domestic...

To continue reading please take a free trial, subscribe or login below.


Already have an account?

Subscribe

Subscribe now for unlimited access to all current and archive news, data and market analysis. 

Subscribe

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial

Upcoming Events

Poll

Which area will be most profitable for investment banks in LatAm in 2016?

Vote    




Popular Searches